(China Knowledge) - Beijing Acrobiosystems Biotechnology Co., Ltd, an
international recognized manufacturer of recombinant proteins committed to
supporting cancer immunotherapy, recently announced that its U.S.-based parent
company has launched a PD1-PDL1 inhibitor screening assay kit that will
significantly improve efficiency for screening and profiling.
Also a specialist in mammalian cell-based recombinant protein production
and process development, the biotech firm has its headquarters located in
The PD1-PDL1 pathway inhibitor screening kit, the first of its kind in
China, works by testing candidate inhibitors' efficiency in blockade of the
PD1-PDL1 pathway. The kit is highly sensitive and efficient, and can be repetitively
used on a large scale. Removing the need for carrying out parallel comparative
experiments as the drug industries used to do, the kit facilitates massive
one-time screening. In combination with biotin labelling technology, the kit
can help bridge the differences caused by unstable experiment conditions.
This new product is set to hit the market having received rave reviews
from several Chinese and foreign drug R&D companies in pre- market tests.
Acrobiosystems will launch more immunosuppression pathway assay kits to cater
to demand from pharmaceutical companies.
Biomedicine, as an emerging industry of strategic significance in China,
is one of the ten areas highlighted in a ten-year national plan known as
"Made in China 2025" and is also one of the leading industries high
on the agenda of Beijing E-Town, a triple-A rated industrial parks in China.
In recent years, many high-end biotech firms including Beijing
Acrobiosystems have made their headquarters in Beijing E-Town's biomedicine
park, allured by its preferential investment policies.
In addition, some fortune 500 companies, such as Benz Daimler Chrysler,
GE, Bosch, Corning, Danieli, Kimberly-Clark, LG, Cummins, Bayer, ABB,
Panasonic, Schneider, SMIC and BOE, have chosen Beijing E-Town as their HQ or
R&D base in China.
With backing from Beijing Municipal of Science and Technology
Commission, Beijing E-Town will attract more investments and expertise in the